FDA Approves rfxcel for Verification Router Service (VRS) Pilot

rfxcel, the global leader in supply chain compliance and serialization solutions, has been approved by the U.S. Food and Drug Administration (FDA) to conduct a pilot to extend the testing of the Verification Router Service (VRS) for saleable returns.

rfxcel will work with pharmaceutical supply chain partners of all sizes to extend the testing to ensure that all edge-cases are verified and ensure that interoperability readiness is quantified.

As part the pilot, rfxcel will share the details of its VRS test cases with all VRS providers to ensure they have a common detailed set of test cases. rfxcel will work with the providers to verify the test conditions to enable maximum readiness of the VRS network across all VRS providers.

“We are excited to continue the effort started by the HDA, and we are honored to be approved by the FDA for the VRS pilot,” said rfxcel CEO Glenn Abood. “The pilot seeks to measure and ensure the seamless interoperability between VRS providers across a broad range of use cases. Complete and consistent verification of the use cases is critical to successfully meeting the DSCSA saleable returns requirement.

“We are working with other VRS providers and supply chain partners of all sizes to ensure proper representation in the VRS pilot,” Abood continued. “As a first step, rfxcel will begin sharing our test cases with all VRS providers to set the stage for an open work environment among all participants.”